ABVC: שווי חברה לרווח נקי ABVC BioPharma Inc

The growth in value of ABVC BioPharma is driven by successful trials of plant-based treatments for depression and ADHD, payments from Asian partners, and FDA support. This chart reflects the current market value at -3.80. ABVC BioPharma develops low-toxicity drugs for the therapy of neurological disorders and cancer, utilizing unique patented plant extracts to combat severe pathologies.
פילוחי מדדים מקיפים ואנליטיקה עבור ABVC BioPharma Inc (ABVC)

The P/E ratio determines the market value of one ruble of net profit, reflecting investor expectations regarding capital payback rates and cost management efficiency. By analyzing the P/E chart for ABVC BioPharma (ABVC), one can assess the company's resilience to geopolitical risks, which directly impact operating profitability and the final market valuation of the business through international supply chain disruptions and patent complexities.